Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 123

    1.

    Approaches towards expression profiling the response to treatment.

    Sims AH, Bartlett JM.

    Breast Cancer Res. 2008;10(6):115. Epub 2008 Dec 8.

    PMID:
    19144210
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.

    Iorio MV, Casalini P, Tagliabue E, Ménard S, Croce CM.

    Eur J Cancer. 2008 Dec;44(18):2753-9. Epub 2008 Nov 18. Review.

    PMID:
    19022662
    [PubMed - indexed for MEDLINE]
    3.

    Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis.

    André F, Michiels S, Dessen P, Scott V, Suciu V, Uzan C, Lazar V, Lacroix L, Vassal G, Spielmann M, Vielh P, Delaloge S.

    Lancet Oncol. 2009 Apr;10(4):381-90. Epub 2009 Feb 25.

    PMID:
    19249242
    [PubMed - indexed for MEDLINE]
    4.

    Expression profiling technology: its contribution to our understanding of breast cancer.

    Rakha EA, El-Sayed ME, Reis-Filho JS, Ellis IO.

    Histopathology. 2008 Jan;52(1):67-81. Review.

    PMID:
    18171418
    [PubMed - indexed for MEDLINE]
    5.

    [Histopathologic diagnosis of luminal and basal type breast cancer].

    Sarcević B.

    Acta Med Croatica. 2008 Oct;62(4):427-30. Croatian.

    PMID:
    19205420
    [PubMed - indexed for MEDLINE]
    6.

    Predicting endocrine therapy responsiveness in breast cancer.

    Ma CX, Sanchez CG, Ellis MJ.

    Oncology (Williston Park). 2009 Feb;23(2):133-42. Review.

    PMID:
    19323294
    [PubMed - indexed for MEDLINE]
    7.

    Trawling for genes that predict response to breast cancer adjuvant therapy.

    Ellis M, Ballman K.

    J Clin Oncol. 2004 Jun 15;22(12):2267-9. Epub 2004 May 10. No abstract available.

    PMID:
    15136594
    [PubMed - indexed for MEDLINE]
    8.

    Predicting response to docetaxel neoadjuvant chemotherapy for advanced breast cancers through genome-wide gene expression profiling.

    Zembutsu H, Suzuki Y, Sasaki A, Tsunoda T, Okazaki M, Yoshimoto M, Hasegawa T, Hirata K, Nakamura Y.

    Int J Oncol. 2009 Feb;34(2):361-70.

    PMID:
    19148470
    [PubMed - indexed for MEDLINE]
    9.

    Review of gene-expression profiling and its clinical use in breast cancer.

    Stadler ZK, Come SE.

    Crit Rev Oncol Hematol. 2009 Jan;69(1):1-11. Epub 2008 Jul 9. Review.

    PMID:
    18614375
    [PubMed - indexed for MEDLINE]
    10.

    Understanding tumor profiling and assessing treatment.

    Hyams DM.

    Manag Care. 2008 Jul;17(7 Suppl 7):4-8; discussion 17-8. Review.

    PMID:
    19093336
    [PubMed - indexed for MEDLINE]
    11.

    Copy number alterations that predict metastatic capability of human breast cancer.

    Zhang Y, Martens JW, Yu JX, Jiang J, Sieuwerts AM, Smid M, Klijn JG, Wang Y, Foekens JA.

    Cancer Res. 2009 May 1;69(9):3795-801. Epub 2009 Mar 31.

    PMID:
    19336569
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Molecular markers of breast axillary lymph node metastasis.

    Cavalli LR.

    Expert Rev Mol Diagn. 2009 Jul;9(5):441-54. Review.

    PMID:
    19580429
    [PubMed - indexed for MEDLINE]
    13.

    Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole.

    Miller WR, Larionov A, Renshaw L, Anderson TJ, Walker JR, Krause A, Sing T, Evans DB, Dixon JM.

    J Clin Oncol. 2009 Mar 20;27(9):1382-7. Epub 2009 Feb 17.

    PMID:
    19224856
    [PubMed - indexed for MEDLINE]
    14.

    Gene expression profiling: decoding breast cancer.

    de Snoo F, Bender R, Glas A, Rutgers E.

    Surg Oncol. 2009 Dec;18(4):366-78. Review.

    PMID:
    19879448
    [PubMed - indexed for MEDLINE]
    15.

    Gene expression profiling of breast cancer to select women for adjuvant chemotherapy.

    [No authors listed]

    Technol Eval Cent Asses Program Exec Summ. 2008 Apr;22(13):1-8. No abstract available.

    PMID:
    18663816
    [PubMed - indexed for MEDLINE]
    16.

    Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.

    Huber KE, Carey LA, Wazer DE.

    Semin Radiat Oncol. 2009 Oct;19(4):204-10. Review.

    PMID:
    19732684
    [PubMed - indexed for MEDLINE]
    17.

    Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer.

    Kok M, Koornstra RH, Margarido TC, Fles R, Armstrong NJ, Linn SC, Van't Veer LJ, Weigelt B.

    J Pathol. 2009 Jul;218(3):316-26.

    PMID:
    19353633
    [PubMed - indexed for MEDLINE]
    18.

    Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer.

    Waltersson MA, Askmalm MS, Nordenskjöld B, Fornander T, Skoog L, Stål O.

    Int J Oncol. 2009 Feb;34(2):441-8.

    PMID:
    19148479
    [PubMed - indexed for MEDLINE]
    19.

    Surgery in the era of gene expression profiling-based prediction and individualized, neoadjuvant breast cancer therapy: the beginning of the end?

    Roukos DH, Paraskevaidis E, Kappas AM.

    Ann Surg Oncol. 2006 Mar;13(3):433-5. No abstract available.

    PMID:
    16450216
    [PubMed - indexed for MEDLINE]
    20.

    Comparison of prognostic gene profiles using qRT-PCR in paraffin samples: a retrospective study in patients with early breast cancer.

    Espinosa E, Sánchez-Navarro I, Gámez-Pozo A, Marin AP, Hardisson D, Madero R, Redondo A, Zamora P, San José Valiente B, Mendiola M, González Barón M, Fresno Vara JA.

    PLoS One. 2009 Jun 15;4(6):e5911.

    PMID:
    19547727
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk